1 MONTELUKAST SODIUM | 40 of 1080 | 4210 prescriptions Less than 1% of all prescriptions | 3750 | 950 patients 27% of all patients | < 11 | |
2 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 10 of 1240 | 3780 prescriptions Less than 1% of all prescriptions | 3190 | 870 patients 25% of all patients | 750 patients 22% of all patients | |
3 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 50 of 1080 | 3090 prescriptions Less than 1% of all prescriptions | 2920 | 720 patients 21% of all patients | < 11 | |
4 PREDNISONE | 120 of 1220 | 2400 prescriptions Less than 1% of all prescriptions | 2000 | 1050 patients 30% of all patients | 900 patients 26% of all patients | |
5 VENTOLIN HFA (ALBUTEROL SULFATE) | 120 of 1260 | 2020 prescriptions Less than 1% of all prescriptions | 1680 | 720 patients 21% of all patients | < 11 | |
6 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 240 of 1070 | 1210 prescriptions Less than 1% of all prescriptions | | 360 patients 10% of all patients | < 11 | |
7 SPIRIVA (TIOTROPIUM BROMIDE) | 150 of 1050 | 960 prescriptions Less than 1% of all prescriptions | | 240 patients 7% of all patients | < 11 | |
8 PROAIR HFA (ALBUTEROL SULFATE) | 100 of 1130 | 1440 prescriptions Less than 1% of all prescriptions | 1130 | 540 patients 16% of all patients | < 11 | |
9 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 180 of 960 | 1120 prescriptions Less than 1% of all prescriptions | 980 | 230 patients 7% of all patients | < 11 | |
10 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 240 of 980 | 780 prescriptions Less than 1% of all prescriptions | | 210 patients 6% of all patients | < 11 | |
11 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 50 of 620 | 710 prescriptions Less than 1% of all prescriptions | 490 | 160 patients 5% of all patients | < 11 | |
12 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 80 of 380 | 410 prescriptions Less than 1% of all prescriptions | 410 | 120 patients 3% of all patients | 120 patients 3% of all patients | |
13 FLUTICASONE PROPIONATE | 320 of 890 | 380 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 FUROSEMIDE | 120 of 500 | 400 prescriptions Less than 1% of all prescriptions | | 150 patients 4% of all patients | < 11 | |
15 FLOVENT HFA (FLUTICASONE PROPIONATE) | 230 of 430 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
16 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 690 of 1050 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 ZOLPIDEM TARTRATE | 140 of 300 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
18 FLOVENT DISKUS (FLUTICASONE PROPIONATE) | 110 of 230 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 GLASSIA (ALPHA-1-PROTEINASE INHIBITOR) | 30 of 40 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
20 THEOPHYLLINE ANHYDROUS | 110 of 180 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
21 LEVOFLOXACIN | 120 of 420 | 300 prescriptions Less than 1% of all prescriptions | | 230 patients 7% of all patients | < 11 | A |
22 AZATHIOPRINE | 70 of 90 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
23 CEFUROXIME (CEFUROXIME AXETIL) | 60 of 150 | 230 prescriptions Less than 1% of all prescriptions | | 190 patients 5% of all patients | < 11 | A |
24 FLUCONAZOLE | 40 of 60 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 170 of 310 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
26 AZITHROMYCIN | 560 of 960 | 140 prescriptions Less than 1% of all prescriptions | | 120 patients 3% of all patients | < 11 | A |